Evidence map›Paper›PMID 19479034›Full record

ArticlePloS one2009

Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs.

Heather B Miller, Kevin O Saunders, Georgia D Tomaras, Mariano A Garcia-Blanco

Abstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Early Splicing Complexes and Human Disease.International journal of molecular sciences · 2023
    Review
  3. Proteomic Analysis ofPathogens (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Heather B MillerDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Kevin O Saunders
Georgia D Tomaras
Mariano A Garcia-Blanco

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
HIV-1 Gene Suppression by CD8+ T CellsR01AI052779 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2003 to 2010
$1.9M
Connections between mRNA elongation and splicingR01GM071037 · NIGMS · DUKE UNIVERSITY · PI GARCIABLANCO, MARIANO A. · 2004 to 2007
$1.4M
NIAID NIH HHS P30 AI064518NIAID NIH HHS P30 AI 64518NIAID NIH HHS R01 AI052779NIAID NIH HHS R01-AI052779NIAID NIH HHS UC6 AI058607NIGMS NIH HHS R01 GM071037NIGMS NIH HHS R01-GM071037
6 · The paper itself

Abstract

backgroundHIV-1 relies on several host proteins for productive viral transcription. HIV-1 Tat-specific factor 1 (Tat-SF1) is among these cofactors that were identified by in vitro reconstituted transcription reactions with immunodepleted nuclear extracts. At the onset of this work, the prevailing hypothesis was that Tat-SF1 was a required cofactor for the viral regulatory protein, Tat; however, this had not previously been formally tested in vivo. METHODOLOGY/PRINCIPAL

findingsTo directly address the involvement of Tat-SF1 in HIV-1 gene expression, we depleted Tat-SF1 in HeLa cells by conventional expression of shRNAs and in T- Rex -293 cells containing tetracycline-inducible shRNAs targeting Tat-SF1. We achieved efficient depletion of Tat-SF1 and demonstrated that this did not affect cell viability. HIV-1 infectivity decreased in Tat-SF1-depleted cells, but only when multiple rounds of infection occurred. Neither Tat-dependent nor basal transcription from the HIV-1 LTR was affected by Tat-SF1 depletion, suggesting that the decrease in infectivity was due to a deficiency at a later step in the viral lifecycle. Finally, Tat-SF1 depletion resulted in an increase in the ratio of unspliced to spliced viral transcripts. CONCLUSIONS/SIGNIFICANCE: Tat-SF1 is not required for regulating HIV-1 transcription, but is required for maintaining the ratios of different classes of HIV-1 transcripts. These new findings highlight a novel, post-transcriptional role for Tat-SF1 in the HIV-1 life cycle.

Indexed as

Cell SurvivalHeLa CellsHIV-1HIV Long Terminal RepeatHumansRNA SplicingRNA, Viraltat Gene Products, Human Immunodeficiency VirusTrans-ActivatorsTranscriptional ActivationTranscription, GeneticVirus ReplicationHTATSF1 protein, humanRNA, Viraltat Gene Products, Human Immunodeficiency VirusTrans-Activators

Identifiers

PMID19479034
PMCPMC2682658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.